PEAK6 Investments’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

PEAK6 Investments’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-7,900	Closed	-$692K	–	5024
2020 Q1	$692K	Sell	7,900 -8,000	-50%	-$847K	﹤0.01%	1804
2019 Q4	$1.66M	Sell	15,900 -16,100	-50%	-$1.81M	0.01%	1215
2019 Q3	$3.68M	Buy	32,000 +5,200	+19%	+$789K	0.02%	882
2019 Q2	$4.62M	Buy	26,800 +6,700	+33%	+$1.16M	0.03%	751
2019 Q1	$3.39M	Sell	20,100 -43,700	-68%	-$6.5M	0.02%	939
2018 Q4	$6.21M	Buy	63,800 +100	+0.2%	+$13.1K	0.04%	523
2018 Q3	$11M	Buy	+63,700	New	+$9.19M	0.05%	427

Other funds holding GWPH

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PEAK6 Investments's GWPH Position: Q1 2021 in Review

PEAK6 Investments sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 3,971 shares — an estimated $458K sold.

PEAK6 Investments first reported a position in GWPH in Q4 2018 and held it in 7 quarters. The position peaked at $2.25M in Q3 2019. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

PEAK6 Investments reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
PEAK6 Investments sold 3,971 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $458K.
PEAK6 Investments first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2018 and held it in 7 quarters.
PEAK6 Investments's GW Pharmaceuticals Plc American Depositary Shares position peaked at $2.25M in Q3 2019.
297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on PEAK6 Investments's 13F filing for Q1 2021, filed 14 May 2021.